{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T08:09:14Z","timestamp":1748333354375},"reference-count":21,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T00:00:00Z","timestamp":1180051200000},"content-version":"vor","delay-in-days":935,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2004,11]]},"abstract":"<jats:p> <jats:italic>The emerging role of aldosterone in hypertension and cardiovascular diseases has prompted a renewal of interest in therapeutic approaches designed to interfere with the action of this mineralocorticoid hormone. While spironolactone has long been used for this purpose, side effects, largely attributable to the interaction of this agent with non\u2010mineralocorticoid steroid receptors, has reduced the enthusiasm for its use. Eplerenone, a specific aldosterone receptor blocker with a lower incidence of the sex hormone\u2010related side effects than spironolactone, has been used in several recent clinical trials in hypertension and congestive heart failure. This review will highlight the major findings from these studies.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1524-6175.2004.03057.x","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T15:59:31Z","timestamp":1180108771000},"page":"632-635","source":"Crossref","is-referenced-by-count":3,"title":["The Use of Aldosterone Receptor Blockers in the Treatment of Hypertension"],"prefix":"10.1111","volume":"6","author":[{"given":"Myron H.","family":"Weinberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,5,25]]},"reference":[{"key":"e_1_2_9_2_2","first-page":"650","article-title":"Three new epoxy spironolactone derivatives: characterization in vivo and in vitro","volume":"240","author":"Gasparo M","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90240-D"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000071081.35693.9A"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.5.1730"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0910457"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.10.1056"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8651(05)70207-1"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000039104.56479.42"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045415-200203000-00008"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-001-0046-2"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)02957-6"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00461-2"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00054-8"},{"key":"e_1_2_9_15_2","article-title":"Effects of eplerenone versus losartan in patients with low\u2010renin hypertension","author":"Weinberger MH","journal-title":"Am Heart J"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)91030-7"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(89)90169-6"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000025146.19104.FE"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000091405.00772.6E"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.13.1543"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1524-6175.2004.03057.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1524-6175.2004.03057.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1524-6175.2004.03057.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1524-6175.2004.03057.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:49:26Z","timestamp":1694422166000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1524-6175.2004.03057.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1111\/j.1524-6175.2004.03057.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-6175.2004.03057.x","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}